Ra Pharmaceuticals to Present at the 2018 Cantor Global Healthcare Conference
September 25 2018 - 4:05PM
Business Wire
Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that Doug
Treco, PhD, President and Chief Executive Officer of Ra Pharma,
will present at the 2018 Cantor Global Healthcare Conference on
Tuesday, October 2, 2018 at 9:10 a.m. E.T. The conference is being
held at the InterContinental New York Barclay Hotel.
The presentation will be webcast live and can be accessed by
visiting the investor relations section of the Company’s
website, www.rapharma.com. A replay of the presentation will
also be available and archived on the site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical
company focusing on the development of next-generation therapeutics
for complement-mediated diseases. The Company discovers and
develops peptides and small molecules to target key components of
the complement cascade. For more information, please
visit: www.rapharma.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180925005948/en/
Investors:Argot PartnersNatalie Wildenradt,
212-600-1902natalie@argotpartners.comorMedia:Argot PartnersDavid
Rosen, 212-600-1902david.rosen@argotpartners.com
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Sep 2023 to Sep 2024